Literature DB >> 22724075

Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.

Gauri H Malthankar-Phatak1, Yin-Guo Lin, Nicholas Giovannone, Robert Siman.   

Abstract

It has been challenging to develop transgenic and gene-targeted mouse models that recapitulate all of the neuropathological features of Alzheimer's disease (AD). For example, in the APP/PS-1 double knock-in mutant mouse (DKI), frank neurodegeneration is not observed at middle age and synapse loss is pronounced only within amyloid plaques. Here, we investigated whether continued amyloid deposition and advanced age of 24-27 months lead to loss of neurons and synapses, tau hyperphosphorylation, and other pathological features of AD. We focused on the perforant pathway projection from entorhinal cortex to hippocampal dentate gyrus, since it is preferentially impacted by plaques, tangles, and neuronal loss early in the course of AD. Compared with wild type controls matched for age and gender, expression of neither reelin nor NeuN was altered in the entorhinal layer 2 neurons of origin. Retrograde labeling of the perforant pathway with Fluorogold indicated no cell loss, axonal atrophy, or nerve terminal degeneration. The lack of neuronal loss or atrophy was confirmed by volumetric analysis of the ventral dentate gyrus and immunostaining for a synaptic marker. We also searched for other hallmarks of AD neuropathology by labeling for hyperphosphorylated pre-tangle tau, accumulation of cathepsin D-containing autolysosomes, and cyclin A-positive neurons aberrantly re-entering the cell cycle. None of these AD pathologies were observed in the entorhinal cortex, dentate gyrus, or any other forebrain region. Our results indicate that the DKI mouse does not show appreciable Alzheimer-type disease progression, even at advanced age and in the phase of over 18 months of robust cerebral amyloid deposition. The insufficiency of amyloid deposition to induce other AD-type neuropathologies and neurodegeneration in the aging mouse brain suggests an important role for tauopathy or other factors for triggering the pathogenesis of AD.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; aging; cathepsin D; neuronal degeneration; tau

Year:  2011        PMID: 22724075      PMCID: PMC3377826     

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  61 in total

1.  DNA replication precedes neuronal cell death in Alzheimer's disease.

Authors:  Y Yang; D S Geldmacher; K Herrup
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

Review 2.  Transgenic mouse models of Alzheimer's disease.

Authors:  B J Hock; B T Lamb
Journal:  Trends Genet       Date:  2001-10       Impact factor: 11.639

3.  Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease.

Authors:  Karl Herrup; Thomas Arendt
Journal:  J Alzheimers Dis       Date:  2002-06       Impact factor: 4.472

4.  Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation.

Authors:  R Siman; D G Flood; G Thinakaran; R W Neumar
Journal:  J Biol Chem       Date:  2001-09-26       Impact factor: 5.157

Review 5.  Species differences in the projections from the entorhinal cortex to the hippocampus.

Authors:  Thomas van Groen; Inga Kadish; J Michael Wyss
Journal:  Brain Res Bull       Date:  2002 Feb-Mar 1       Impact factor: 4.077

6.  Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology.

Authors:  Anne M Cataldo; Corrinne M Peterhoff; Stephen D Schmidt; Nicole B Terio; Karen Duff; Margaret Beard; Paul M Mathews; Ralph A Nixon
Journal:  J Neuropathol Exp Neurol       Date:  2004-08       Impact factor: 3.685

7.  Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.

Authors:  Claudia Schwab; Masato Hosokawa; Patrick L McGeer
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

8.  FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.

Authors:  Dorothy G Flood; Andrew G Reaume; Karen S Dorfman; Yin Guo Lin; Diane M Lang; Stephen P Trusko; Mary J Savage; Wim G Annaert; Bart De Strooper; Robert Siman; Richard W Scott
Journal:  Neurobiol Aging       Date:  2002 May-Jun       Impact factor: 4.673

9.  Gamma-secretase subunit composition and distribution in the presenilin wild-type and mutant mouse brain.

Authors:  R Siman; S Salidas
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  NeuN, a neuronal specific nuclear protein in vertebrates.

Authors:  R J Mullen; C R Buck; A M Smith
Journal:  Development       Date:  1992-09       Impact factor: 6.868

View more
  8 in total

1.  Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer's Disease Cell Model via Upregulation of MicroRNA-9.

Authors:  Shaoheng Li; Yuhui Yan; Yanan Jiao; Zhong Gao; Yang Xia; Liang Kong; Yingjia Yao; Zhenyu Tao; Jie Song; Yaping Yan; Guangxian Zhang; Jingxian Yang
Journal:  J Mol Neurosci       Date:  2016-07-09       Impact factor: 3.444

Review 2.  Toward more predictive genetic mouse models of Alzheimer's disease.

Authors:  Kristen D Onos; Stacey J Sukoff Rizzo; Gareth R Howell; Michael Sasner
Journal:  Brain Res Bull       Date:  2015-12-17       Impact factor: 4.077

Review 3.  Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition.

Authors:  Paul Denver; Paula L McClean
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

4.  Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer's disease-like pathologies in APP/PS1 mouse model.

Authors:  Cui-Cui Yang; Xiao-Yu Jia; Li Zhang; Ya-Li Li; Zhan-Jun Zhang; Lin Li; Lan Zhang
Journal:  Chin Herb Med       Date:  2020-10-06

5.  Synaptic changes in the dentate gyrus of APP/PS1 transgenic mice revealed by electron microscopy.

Authors:  Lidia Alonso-Nanclares; Paula Merino-Serrais; Santiago Gonzalez; Javier DeFelipe
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

6.  The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer's disease.

Authors:  Hannah Brautigam; John W Steele; David Westaway; Paul E Fraser; Peter H St George-Hyslop; Sam Gandy; Patrick R Hof; Dara L Dickstein
Journal:  Mol Neurodegener       Date:  2012-11-22       Impact factor: 14.195

7.  Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?

Authors:  Dena B Dubal; Lauren Broestl; Kurtresha Worden
Journal:  Biol Sex Differ       Date:  2012-11-05       Impact factor: 5.027

Review 8.  APP mouse models for Alzheimer's disease preclinical studies.

Authors:  Hiroki Sasaguri; Per Nilsson; Shoko Hashimoto; Kenichi Nagata; Takashi Saito; Bart De Strooper; John Hardy; Robert Vassar; Bengt Winblad; Takaomi C Saido
Journal:  EMBO J       Date:  2017-08-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.